Self-reported experience in patients treated with Hepatitis C direct acting antivirals
Background and objective: To learn about and analyze the self-reported treatment experience of HCV patients who started treatment with direct acting antivirals agents (DAA), at a real-time, proactive and integrated into the pharmaceutical care healthcare process, using a prospective questionnaire c...
Main Authors: | Irene Cañamares Orbis, Javier Saez de la Fuente, Ismael Escobar Rodriguez, Concepción Esteban Alba, Ana Such Díaz, Ismael Escobar Rodríguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Grupo Aula Médica
2016-12-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/10503.pdf |
Similar Items
-
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir
by: Ng X, et al.
Published: (2018-12-01) -
The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals
by: Richmond JA, et al.
Published: (2016-12-01) -
The efficacy and safety of direct-acting antiviral drugs in the management of hepatitis C virus-related arthritis
by: Samah M. Alian, et al.
Published: (2020-09-01) -
Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis
by: Haruna Yamamoto, et al.
Published: (2018-07-01) -
Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
by: Elfi Egmond, et al.